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Abstract
Alcelaphine herpesvirus–1 (AlHV-1), a causative agent of malignant catarrhal fever in cattle,
was detected in wildebeest (Connochaetes taurinus) placenta tissue for the first time. Al-
though viral load was low, the finding of viral DNA in over 50% of 94 samples tested lends sup-
port to the possibility that placental tissue could play a role in disease transmission and that
wildebeest calves are infected in utero. Two viral loci were sequenced to examine variation
among virus samples obtained from wildebeest and cattle: the ORF50 gene, encoding the
lytic cycle transactivator protein, and the A9.5 gene, encoding a novel polymorphic viral glyco-
protein. ORF50 was well conserved with six newly discovered alleles differing at only one or
two base positions. In contrast, while only three new A9.5 alleles were discovered, these dif-
fered by up to 13% at the nucleotide level and up to 20% at the amino acid level. Structural ho-
mology searching performed with the additional A9.5 sequences determined in this study
adds power to recent analysis identifying the four-helix bundle cytokine interleukin-4 (IL4) as
themajor homologue. The majority of MCF virus samples obtained from Tanzanian cattle and
wildebeest encoded A9.5 polypeptides identical to the previously characterized A9.5 allele
present in the laboratory maintained AlHV-1 C500 strain. This supports the view that AlHV-1
C500 is suitable for the development of a vaccine for wildebeest-associated MCF.
Introduction
Malignant catarrhal fever (MCF) is a fatal systemic disease of a range of species—mainly un-
gulate—that is caused by members of a group of related herpesviruses, belonging to the genus
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Macavirus in the sub-family gammaherpesvirus. Although the best studied members of this genus
are ovine herpesvirus-2 (OvHV-2) [1],[2] and alcelaphine herpesvirus-1 (AlHV-1) [1],[3], MCF
has also been associated with infection by caprine herpesvirus-2 (CpHV-2) [4],[5], the MCF virus
of white-tailed deer (Odocoileus virginianus) (MCFV-WTD) [6],[7] and alcelaphine herpesvirus-2
(AlHV-2) [8],[9],[10]. These viruses share contrasting abilities to propagate infectious virus with-
out inducing clinical signs within specific reservoir host species (sheep for OvHV-2; wildebeest
(Connochaetes taurinus) for AlHV-1; Topi (Damaliscus lunatus) for AlHV-2; and goat for CpHV-
2) and also to induce fatal MCF, without the production of infectious virus, in selected MCF-sus-
ceptible species including bison (Bison bonasus), cattle, deer and others [11]-[12].
Reservoir species generally shed MCF virus in ocular and nasal secretions on an irregular
basis, in keeping with the latent nature of herpesvirus infections [13],[14]. The ability to induce
MCF in susceptible species (and by inference to shed infectious virus) appears to be limited to
periods of detectable viraemia in the reservoir species. For AlHV-1, it has been suggested that
viraemia in wildebeest calves is at its highest in the first three months of life, and thereafter shed-
ding ceases [15]. For OvHV-2, virus appears to be shed intermittently in nasal secretions of la-
tently infected sheep, with adolescents representing the highest risk group for transmission [16].
Experimentally, MCF can be induced and infectivity maintained by inoculation of infected
cells in to susceptible hosts [17,18] or by intranasal inoculation with cell-free virus [19,20]. Nat-
ural transmission of MCF viruses, however, is generally considered to be via inhalation or inges-
tion of infectious cell-free virus shed in the mucous secretions of reservoir hosts. The induction
of MCF in cattle following inoculation with tissue suspensions from wildebeest foetal liver or
spleen, however, suggested that intrauterine transmission of AlHV-1 could also occur. This was
supported by the detection of virus in the spleen of one wildebeest foetus and in the blood of
three wildebeest calves less than one week old [3].
Tanzanian pastoralists view the calving wildebeest as the main source of MCF, with MCF
transmission from placenta, foetal membranes, foetal fluid or calf hair (moulted at 3–4
months) considered a high risk [21]. These Maasai perceptions of placental involvement in
MCF transmission are firmly held but are not supported by the available evidence despite
demonstrations of apparent intra-uterine infection of wildebeest calves [3],[15],[22],[23].
The availability of diagnostic PCR now makes it possible to analyse placental tissue samples
for the presence of AlHV-1.
The novel spliced gene A9.5 is predicted to encode a secreted glycoprotein that has no ho-
mologue outside the MCF viruses [24]. A9.5 does have a detectable homologue in OvHV-2
(Ov9.5) that has been shown to be both polymorphic and highly variable with nine alleles
showing as little as 50% predicted amino acid sequence identity [25]. So far, only two alleles of
A9.5 have been identified: one (A9.50101] [24] in the C500 strain of AlHV-1, that has been
passaged in vivo in the UK for almost 50 years [26], and the other (A9.50201) [27] in a diag-
nostic sample taken from an Ankole cow with MCF. The A9.5 alleles share about 80% amino
acid sequence identity and retain overall similarity to the Ov9.5 alleles. It is expected that anal-
ysis of this gene in a range of samples from wildebeest and cattle with MCF will allow im-
proved epidemiological analysis of MCF. Of particular interest for this study is the potential
for comparative analysis of AlHV-1 from two wildebeest populations in East Africa that have
been geographically isolated from each other [28]. Of added interest will be the comparison of
these strains with the C500 virus which has been the strain of choice for recent vaccine devel-
opment [20,29].
MCF reservoir species frequently have neutralising antibodies that react with AlHV-1 and
appear to share a specific epitope in the major virus glycoprotein complex [30]. Thus, serologi-
cal analysis of wildebeest blood samples might be used to detect past infection even when latent
virus levels in the blood are below the limit of detection by PCR.
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In this paper we describe the first analysis by PCR of AlHV-1 DNA from wildebeest placen-
tal samples and DNA sequence-based analysis of virus diversity among AlHV-1 samples from
both wildebeest and cattle.
Materials and Methods
Biological samples for analysis of AlHV-1 infection were collected from four sources and are
detailed in Table 1:
i. Wildebeest calf and dam
Uncoagulated blood samples were collected from two wildebeest populations resident in Tanza-
nia: i. The Ngorongoro Crater population, which despite residing in the Crater for long periods
of time are known to occasionally disperse and mingle with the population resident in the wider
Serengeti ecosystem; ii. The Tarangire population, which live predominantly in the vicinity of
Tarangire National Park. The two populations are separate, both in the geographical and evolu-
tionary sense [28]. All sampled wildebeest were immobilized using etorphine hydrochloride
(Captivon, Wildlife Pharmaceuticals, Karino, South Africa) and all blood samples were collected
by jugular venipuncture directly in to Vacutainer collection tubes. Samples from three dams
and five approximately 32-day-old calves were collected from the Ngorongoro Crater popula-
tion and from five approximately 100-day-old calves from the Tarangire population. The ages
of the calves could be accurately judged as the wildebeest calving season, for which the authors
recorded the start date, is highly synchronised and only lasts a few days. Buffy coat cells pre-
pared from the blood samples were stored on FTA cards prior to DNA extraction, while blood
plasma was stored at minus 20°C.
ii. Wildebeest placenta
Samples of freshly passed wildebeest placenta from the Ngorongoro Crater population, con-
sisted of approximately 1 cm3 of full thickness tissue. To collect these samples field teams fol-
lowed calving wildebeest waiting for the placenta to be expelled. As soon as the placenta fell
away from the dam, approximately 45 minutes after the calf was born, the team would drive up
to the placenta and collect the tissue sample. None of the dams paid any attention to their pla-
centa, and there was no licking or sniffing observed. Consequently we consider all samples to
Table 1. Details of each sample set and summarized results of diagnostic assays.
Animal Population /
Location
Sample Sample
Numbers
Real time PCR
positive
Nested PCR
positive
AlHV-1 specific
antibody positive
A9.5 sequences
obtained
Wildebeest Ngorongoro
Crater
Placenta 94 1 50 NA 23
Wildebeest dam Ngorongoro
Crater
Buffy
coat
3 0 1 3 0
Wildebeest calf (32
day old)
Ngorongoro
Crater
Buffy
coat
5 0 5 4 3
Wildebeest calf (100
day old)
Tarangire Buffy
coat
5 0 1 5 1
Cattle (adult) Tarangire Buffy
coat
200 0 59 154* 6
* This number includes 54 out of 100 unvaccinated animals with at least one sample of nasal secretion or blood plasma with MCF-specific ELISA titre
>10. Of these animals, 20 were found to be AlHV-1positive by nested PCR.
doi:10.1371/journal.pone.0124121.t001
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have been uncontaminated with the dam’s ocular or nasal secretion. All samples once collected
were frozen (at minus 20°C) prior to DNA extraction.
iii. MCF vaccine trial cattle
Blood samples, collected by jugular venipuncture directly in to Vacutainer collection tubes as
part of a vaccine trial involving Tanzanian zebu shorthorn cattle living near Tarangire National
Park, were selected for analysis if they came from individuals that had become naturally infected
with MCF virus transmitted by wildebeest calves. Buffy coat cells, prepared from the blood sam-
ples, were stored on FTA cards (Whatman FTA Classic, Thermo Fisher, UK) or frozen (at
minus 20°C) prior to DNA extraction.
iv. C500
The C500 strain of AlHV-1, for which complete genome sequence is available [31], was origi-
nally obtained from an AlHV-1-infected ox in Kenya and passaged in New Zealand White rab-
bits [26] in the UK. Purified AlHV-1 C500 DNA was used as a control in PCR and sequencing
analyses.
AlHV-1 specific antibody reactivity
Duplicate samples of wildebeest blood plasma were tested twice using an AlHV-1 specific di-
rect ELISA, essentially as described previously [29], except that known positive and negative
wildebeest serum samples from the UK were used as controls and to generate standard curves
for determination of AlHV-1-specific antibody titre.
Detection of viral DNA
The presence of AlHV-1 was determined by PCR analysis of DNA extracted from buffy coat
cells and placenta tissue samples. DNA was purified from the frozen cattle buffy coat samples
using the ZR Viral DNA Kit (Zymo Research Corporation, USA); from the FTA card stored
wildebeest buffy coat samples using QiaAmp Mini Kit (Qiagen, Crawley, UK); and from the
frozen placental samples using the Qiagen DNeasy Blood and Tissue Kit. Thereafter viral DNA
was detected and analysed by AlHV-1-specific duplex real-time PCR [32],[29] (targeting the
AlHV-1 ORF3 gene [32] and the genomic β-actin gene [29]) and nested diagnostic PCR [33].
Each set of assays was controlled by the inclusion of known AlHV-1 positive and negative bo-
vine genomic DNA samples and potential cross-contamination between reactions was con-
trolled by the inclusion of template-free reactions. To study viral variation in positive samples,
segments of the ORF50 gene, encoding the lytic cycle trans-activator protein, and of the spliced
A9.5 gene [24] were sequenced and analysed as described previously for OvHV-2 [25]. ORF50
encodes a transcription factor expected to be highly conserved, whilst A9.5 encodes a predicted
glycoprotein of unknown function that has been demonstrated to be polymorphic in both
AlHV-1 and OvHV-2 [25],[24].
PCR amplification of A9.5 and ORF50 genes
Primers for nested PCR of the A9.5 gene were designed to target conserved areas flanking the
predicted coding region, based on the available sequence of AlHV-1 [31],[24]. Primers for am-
plification of ORF50 (AHVorf50_F, GCC AGG CAG AGG TAT GTG TT and AHVorf50_R,
GGC CGT TGT GGG TAC TGT AT) were chosen within exon 2 of the ORF50 gene, to amplify
a fragment of 543 base pairs for analysis of sequence variation. Primer pairs were designed using
Primer3 (www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) [34]. The amplification
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of A9.5 used a nested PCR strategy described in an earlier publication because a non-nested ap-
proach amplified the gene poorly. This lack of efficiency probably reflects the constraints on
the primer design aimed to amplify the entire A9.5 coding region. In contrast, the primer design
for ORF50 required only amplification of a fragment of the gene. These primers amplified the
ORF50 segment efficiently without the need for a nested approach.
Amplification of ORF50 and A9.5 gene segments was attempted from genomic DNA sam-
ples in which AlHV-1 DNA had been detected by diagnostic nested PCR [33]. For A9.5, a
nested PCR approach was used with initial amplification performed in 25 μl reactions using 1
unit KOD Hot Start DNA polymerase (Merck, Feltham, UK), 50–100 ng of genomic DNA, and
5 pmol each of primers A9.5geneF and A9.5ex6R [24]. Amplification reactions consisted of a
denaturation / activation step at 94°C for 120 s; 30 cycles of 94°C for 30 s, 55°C for 30 s and
70°C for 60 s; and a final extension step at 70°C for 5 minutes. Aliquots of 2 μl from this initial
PCR were then used as templates in nested PCR amplifications using the same enzyme, buffer
and PCR conditions but with 10 pmol per reaction of the nested primers A9.5cdsF and
A9.5cdsR [24]. The AlHV-1 ORF50 segment was amplified in a single reaction using the same
conditions as described above for A9.5 except that 10 pmol per reaction of the AHVorf50_F
and AHVorf50_R primers were used and reactions were amplified using 40 cycles of 94°C for
30 s, 59°C for 30 s and 68°C for 60 s.
The PCR products were analysed by agarose gel electrophoresis, stained with SYBR Safe
DNA Gel Stain (Life Technologies, Paisley, UK) and visualized by UV transillumination before
purification (QIAamp PCR purification system). PCR product concentrations were estimated
after purification using a Nanodrop spectrophotometer (Labtech, Uckfield, UK). Approximate-
ly 300 ng of each PCR product was submitted for bidirectional nucleotide sequencing by Euro-
fins MWGOperon (Ebersberg, Germany), using the internal PCR primers as the sequencing
primers. Electropherograms from each pair of sequencing reactions were assembled to produce
sample consensus sequences for each gene segment amplified.
To confirm that direct sequencing of PCR products produced an accurate representation
of the target sequence in vivo, PCR products of A9.5 from 4 samples were cloned into pGEM-
T-Easy (Promega, Southampton, UK) and at least three clones representing each PCR product
were sequenced.
Bioinformatics
Unless otherwise indicated, all DNA sequence analysis was carried out using DNASTAR Laser-
gene software (V8.0 and above; www.DNASTAR.com). DNA sequence information from each
amplicon was assembled using the SEQMAN program and consensus sequences representing
the region flanked by the PCR primers were derived. Any DNA sample that did not give good
quality sequence traces on both strands was discarded.
The consensus sequences for each sample and locus were aligned using the MUSCLE algo-
rithm [35] or MAFFT [36]. For A9.5, the positions of introns and exons were defined accord-
ing to the annotation of A9.501 [24] and conservation of splice donor and acceptor sequences
was confirmed by visual inspection, while the conservation of a continuous A9.5 open reading
frame was confirmed by generation of predicted A9.5 cDNA sequences and their translation.
Phylogenetic and evolutionary analysis of all sequences was done by maximum likelihood
methods using the programMEGA (version 5 or above; megasoftware.net) [37].
Nucleotide sequence accession numbers
Nucleotide sequences of the gene fragments amplified in this work have been submitted to
the European Nucleotide Archive (ENA; www.ebi.ac.uk/ena) and have been assigned accession
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numbers as follows: AlHV-1 orf500101, LN823968; orf500102, LN823969; orf500103,
LN823970; orf500201, LN823971; orf500301, LN823972; orf500401, LN823973; A9.50202,
LN823974; A9.50203, LN823975; and A9.50301, LN823976.
Approval
The animal ethics committees of the Tanzanian Wildlife Research Institute (TAWIRI) and the
Commission for Science and Technology (COSTECH, Tanzania) approved all aspects of this
study, including all sampling procedures and the animal research that was conducted accord-
ing to international guidelines (permit nos.2011-213-ER-2005-141 and 2012-318-ER-2005-
141). The Ngorongoro Conservation Area Authority and the Tanzanian National Parks Asso-
ciation approved immobilization (using etorphine hydrochloride loaded pressure darts) and
sampling of wildebeest in the Ngorongoro Crater and Tarangire populations respectively.
Ethical clearance
Permission to immobilise wildebeest, to collect placenta and to carry out the MCF vaccine trial
was provided by the Tanzanian Wildlife Research Institute and the Tanzanian Commission
for Science and Technology (permit numbers 2010-259-NA-2005-141 and 2011-213-ER-2005-
141). Permission to import inactivated blood plasma, serum and DNA on FTA cards into Scot-
land was provided by the Scottish Executive Rural Directorate (import licenses POAO(S)/
2011/54, and POAO(S)/2012/37).
Results
Detection of AlHV-1 virus DNA in wildebeest samples
PCR analysis of DNA samples was done by real-time and nested diagnostic PCR assays. The du-
plex real-time PCR assay detected AlHV-1 DNA in none of the wildebeest buffy coat samples
and in only one of the placental samples. All samples showed amplification of the β-actin inter-
nal control [29] and therefore were suitable for PCR. In contrast, the more sensitive nested PCR
method [33] detected viral DNA in buffy coat samples from one of the three dams, in six of the
ten calves and in 50 of the placental samples (summarised in Table 1). The six positive wilde-
beest calf buffy coat samples consisted of all five of the 32-day old calves from the Ngorongoro
Crater population and one of the five 100-day old calves from the Tarangire population.
Antibody reactivity of wildebeest blood samples
AlHV-1 specific antibody titre in blood plasma was measured in all collected wildebeest blood
samples. Results are summarised in Table 1. All but one of the animals tested were positive for
AlHV-1 specific antibodies, with titre values>100. This included two wildebeest dams and
four 100-day-old calves that tested negative for viral DNA by nested PCR. Interestingly, the
single animal that did not have a positive anti-viral antibody titre was a 32-day-old calf that
tested positive for viral DNA by nested PCR.
Sequencing of AlHV-1 loci from wildebeest and cattle
In order to look at viral sequence variation within the AlHV-1 positive samples identified, PCR
fragments representing the variable A9.5 locus were analysed. To determine whether variation
at A9.5 represented a generally high level of sequence variation between AlHV-1 strains, the
ORF50 locus, encoding the lytic regulator RTA, was also analysed.
Alcelaphine Herpesvirus-1 in Wildebeest Placenta
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ORF50
Amplification of ORF50 was attempted from all positive wildebeest samples (placenta and FTA
card preserved buffy coat) and from FTA card preserved cattle samples (Table 1). For all FTA card
preserved buffy coat samples, amplification was unsuccessful. In each case the amplification was re-
peated to confirm the result. ORF50 was successfully amplified from 38 of the 50 AlHV-1-positive
placenta samples (S2 Data). Sequencing of these PCR products identified six distinct ORF50 alleles
(Table 2) that shared more than 99% sequence identity. The majority of positive samples had a se-
quence identical to ORF500101 [31] (the allele carried by the C500 AlHV-1 strain). The other five
alleles had ORF50 sequences that differed at only one or two base positions fromORF500101 (Fig
1 and S1 Fig). Two of the novel alleles (termed ORF500102 and ORF500103) encoded ORF50
proteins with identical sequence to ORF500101, whereas the remaining three novel alleles (0201,
0301 and 0401) encoded ORF50 proteins that differed by one amino acid fromORF500101 and
by two amino acids from each other (S1 Fig).
A9.5
A9.5 could be amplified from 26 of 57 AlHV-1 positive wildebeest samples (three FTA card
preserved buffy coat samples and 23 placenta) and from six of 59 AlHV-1 positive vaccine trial
Table 2. Summary of AlHV-1 genotyping results. (Sample type BC = Buffy Coat; FTA = stored on FTA cards).
Species Wildebeest Cattle
Provenance Ngorongoro Crater Tarangire Tarangire
Age Dam Calf * Calf ** Adult
Sample type Placenta BC FTA BC FTA BC FTA BC
Sample numbers 94 3 5 5 6
A9.5 alleles
A9.5*0101 13 (56%) 0 1 1 3
A9.5*0201$ 0 0 0 0 0
A9.5*0202 0 0 0 0 3
A9.5*0203 5 (22%) 0 1 0 0
A9.5*0301 5 (22%) 0 1 0 0
ORF50 alleles
ORF50*0101 29 (76%) 0 0 0 NA
ORF50*0102 5 (13%) 0 0 0 NA
ORF50*0103 1 (2.6%) 0 0 0 NA
ORF50*0201 1 (2.6%) 0 0 0 NA
ORF50*0301 1 (2.6%) 0 0 0 NA
ORF50*0401 1 (2.6%) 0 0 0 NA
A9.5-ORF50 haplotypes
A9.5*0101 & ORF50*0101 7 (41%) 0 0 0 NA
A9.5*0101 & ORF50*0102 3 (17.6%) 0 0 0 NA
A9.5*0101 & ORF50*0301 1 (5.9%) 0 0 0 NA
A9.5*0203 & ORF50*0101 3 (17.6%) 0 0 0 NA
A9.5*0301 & ORF50*0101 3 (17.6%) 0 0 0 NA
* Calves < 30 days old
** Calves < 100 days old
$ As previously described [24]
doi:10.1371/journal.pone.0124121.t002
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cattle samples (Tables 1, 2 and S1 Data). Four alleles of A9.5 were found among these samples,
sharing at least 87% nucleotide sequence identity (S2 Fig). The majority of samples carried the
A9.50101 allele, whilst the remaining samples carried three alleles which have not been previ-
ously described. These novel alleles were named, in accordance with the previously published
nomenclature, A9.50202, A9.50203 and A9.50301. The novel alleles A9.50202 and
A9.50203 encoded identical proteins to the previously published A9.50201 allele [24], differ-
ing only at two positions in the last intron. Novel allele A9.50301 encoded a protein sequence
with 80% identity with the previously published alleles [24]. A9.50203 and 0301 were found
only in wildebeest from the Ngorongoro Crater population, whilst A9.5 0202 was only found
in cattle living near Tarangire National Park (Table 2). The number of samples with these mi-
nority alleles was too low to allow statistical analysis. Phylogenetic analysis of the A9.5 genomic
and putative spliced cDNA sequences yielded trees with the same topology (Fig 2).
To study possible functional consequences of sequence diversity, the A9.5 protein sequences
were compared with previously established Ov9.5 sequences [25]. Phylogenetic analysis indi-
cated that the A9.5 alleles were less diverse than the Ov9.5 alleles (compare branch lengths in
Fig 3). Within the protein sequence alignment, only 24 of 175 aligned residues were identical
in all sequences, with a further 20 residue positions showing conservation of amino acid prop-
erties (size, charge, hydrophobicity). The fully conserved residues included six cysteines and
five potential N-linked glycosylation sites (Fig 4).
Fig 1. Phylogenetic analysis of AlHV-1 ORF50 gene sequences. Nucleotide sequences of the six variants
ORF50*0101 to ORF50*0401 were aligned using MAFFT and phylogenetic analysis was done in MEGA
version 6.0 using the Maximum Likelihood method, based on the Kimura 2-parameter model [38]. The tree
with the highest log likelihood is shown. There were a total of 503 positions in the final dataset. The tree is
drawn to scale, with branch lengths measured in the number of substitutions per site.
doi:10.1371/journal.pone.0124121.g001
Fig 2. Phylogenetic analysis of A9.5 predicted cDNA sequences. Nucleotide sequences of the six
variants A9.5*0101 to Ov9.5*0301 were aligned using MAFFT and phylogenetic analysis was done in MEGA
version 6.0 using the Maximum Likelihood method, based on the Kimura 2-parameter model [38]. The tree
with the highest log likelihood is shown. The tree is drawn to scale, with branch lengths measured in the
number of substitutions per site. All positions containing gaps and missing data were eliminated. There were
a total of 453 positions in the final dataset.
doi:10.1371/journal.pone.0124121.g002
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The protein sequences aligned in Fig 4 were used to perform structure-based homology
searching using the hhpred server [http://toolkit.teubingen.mpg.de/hhpred]. The top hit was
interleukin-4 (p = 3.2x10-5), with similarity extending over the majority of the mature polypep-
tide (residues 26 to 151 of the alignment). This is in accord with previous suggestions that the
A9.5 and Ov9.5 proteins share structural similarities with four-helix-bundle cytokines, in par-
ticular IL-4 [24] [25].
Fig 3. Phylogenetic analysis of A9.5 and Ov9.5 predicted protein sequences. Nine distinct Ov9.5 and
three distinct A9.5 amino acid sequences were aligned using the Maximum Likelihood method based on the
Whelan And Goldman model [41]. The tree with the highest log likelihood is shown. The tree is drawn to
scale, with branch lengths measured in the number of substitutions per site. All positions containing gaps and
missing data were eliminated. There were a total of 145 positions in the final dataset.
doi:10.1371/journal.pone.0124121.g003
Fig 4. Alignment of A9.5 and Ov9.5 predicted protein sequences. The alignment was done by the Muscle algorithm [35] and conserved residues are
highlighted as follows: residues identical in all sequences are shown in light face on black background; residues of conserved type (hydrophobic/charged/
polar) are shown in black face with grey high-lighting. Residues identical in all sequences are also shown below the alignment on the line labeled ‘conserved’.
doi:10.1371/journal.pone.0124121.g004
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Virus haplotypes
For both ORF50 and A9.5 the most frequent allele detected among animals characterized was
the 0101 allele, the variant carried by the C500 strain of AlHV-1. In the 17 samples that could
be genotyped at both loci, the most common haplotype was also that carried by the C500 virus
(Table 2). All of the other combinations of ORF50 and A9.5 alleles that were detected con-
tained either the ORF500101 or the A9.50101 allele in combination with a different allele at
the second locus (Table 2).
Discussion
In this study we have shown for the first time that AlHV-1 viral DNA can be detected in about
50% of placentae shed by parturient wildebeest. However, the observation that only about 1%
of the same samples had virus detectable by real-time PCR suggests that the viral load in the
wildebeest placentae tested was very low. There are two likely sources of the detected virus: i)
latently infected cells from the dam circulation, which cannot be transmitted in these condi-
tions. This would indicate that the placenta do not play a role in transmission of MCF; and / or
ii) cell-free infectious virus from the calf’s circulation, which would support the view that these
tissues may play a role in the transmission of virus to cattle, as considered by Massai pastoral-
ists [21]. Further work to determine which of these two viral states predominate is required be-
fore conclusions regarding the role that placenta play in transmission can be drawn. The
finding that many wildebeest placenta were infected, however, does support observations that
wildebeest calves can be infected in utero [3],[15],[22].
Among the wildebeest tested, all five of the 32-day old calves from the Ngorongoro Crater
population were positive for AlHV-1 by nested PCR, whilst only one of five 100-day old calves
from the Tarangire population and none of the Ngorongoro Crater dams tested positive. How-
ever, ELISA testing showed evidence of AlHV-1 specific antibodies in all of the wildebeest test-
ed except one calf in the youngest group. This suggests MCF virus-specific antibodies develop
as the calves control the primary infection. These observations together support the view that
infection of most wildebeest calves occurs in utero or within the first month of life. Further-
more, these observations are in accord with previous studies indicating that excretion of
AlHV-1 by wildebeest calves peaks between one and two months of age and thereafter falls. By
six months of age, despite being persistently infected, wildebeest have a very low level of circu-
lating virus-infected cells (undetectable even by the sensitive nested PCR assay) and, consistent
with latent infection, may no longer be capable of transmitting the virus to cattle [15],[39],[40].
Despite the identification of five new alleles, the ORF50 gene was highly conserved within the
samples analysed, with the protein sequences encoded being identical or differing by up to two
amino acids. In contrast, three new A9.5 alleles were characterised, and these encoded proteins that
differed by approximately 20% of residues. It is notable that the A9.5 alleles differed from each
other by less at the nucleotide level (9–13%) than at the amino acid level (19–20%). This is due to
the presence of approximately two-thirds of the allelic differences in the exons and the occurrence
of non-synonymous substitutions in more than half of the affected codons. This is suggestive of
positive selection for variation in A9.5 but no clear evidence is available to support this [24].
Therefore, variation at the A9.5 locus might not be representative of variation across the
whole virus genome. Indeed, while ORF50 is conserved, the A9.5 gene, as has been suggested
for Ov9.5 [25], appears to be subjected to selective pressures that result in the polymorphism
seen. In OvHV-2, nine different alleles of Ov9.5 have been classified [25], compared to the five
A9.5 alleles (Fig 2). The Ov9.5 alleles are more divergent from one another, with 50% amino
acid identity between the most divergent alleles, compared to the A9.5 gene in which the most
divergent alleles have 80% predicted amino acid identity (Fig 3). The strong conservation of
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cysteine residues and potential glycosylation sites across all of the A9.5 and Ov9.5 alleles (Fig
4) suggests that this highly variable protein has conserved structure and function. Recent analy-
sis of the A9.5 and Ov9.5 predicted protein sequences indicated similarity with the four-helix
bundle cytokines, IL4 and IL21 [25]. Structural homology searching performed with the new
A9.5 alleles identified in this study adds power to this analysis, identifying IL4 as the major ho-
mologue with a p-value enhanced from the earlier study. It is currently unclear whether the
similarity with IL4 indicates only a shared structural fold or additional functional similarity.
Among 33 samples for which A9.5 sequences could be derived, only the most frequent allele,
A9.50101, was found in wildebeest samples from both locations and in samples from cattle.
A9.50202 was found only in cattle samples collected near Tarangire National Park, while
A9.50203 and A9.50301 were detected only in wildebeest samples from the Ngorongoro Cra-
ter population. These geographical and species related differences may simply be a conse-
quence of the low number of samples analysed from each site but may also result from the
known isolation of the two wildebeest populations [28]. Unfortunately, ORF50 could only be
amplified from wildebeest placental samples, so it is not possible to make any inferences from
this data. It will be of interest to gather larger numbers of samples from across the range of wil-
debeest-associated MCF to determine the overall extent of AlHV-1 diversity and the epidemi-
ology of MCF viruses in reservoir and susceptible species.
Herpesviruses, being DNA viruses, are typically stable with low rates of nucleotide substi-
tution, as evidenced by the small numbers of base substitutions found among the ORF50 al-
leles sequenced. Thus, the alleles we have identified are likely to have been conserved in the
population for a long period of time. This finding is supported by the fact that the previously
characterized A9.5 alleles present in the C500 virus strain and in a diagnostic sample from
wildebeest-associated MCF in the UK [27] encode A9.5 polypeptides that were identical to
MCF virus fragments amplified from the cattle and wildebeest sampled in the two locations
in Tanzania. Indeed, the most frequent haplotype identified among the Tanzanian samples
was identical to the C500 virus at both the A9.5 and ORF50 loci, whilst all other haplotype
combinations identified included either ORF500101 or A9.50101. This suggests that, like
other herpesviruses which have relatively slow evolutionary molecular clocks [42], the C500
strain of AlHV-1 has remained closely related to AlHV-1 strains circulating in Tanzania, de-
spite it having been propagated in African and European laboratories for approximately 50
years. This supports the view that C500 AlHV-1 remains a suitable strain for the develop-
ment of a vaccine for wildebeest-associated MCF. Furthermore, similarity between the vac-
cine virus and Tanzanian strains of AlHV-1 reduces the risk of a novel, more pathogenic,
virus mutant (derived by recombination between the vaccine virus and local strains of AlHV-
1) escaping into the wild. This makes the AlHV-1 C500 strain safe for vaccination in MCF-
endemic areas.
In summary, we have shown that about 50% of wildebeest placentae tested contained detect-
able AlHV-1 virus (measured as virus DNA), supporting evidence that wildebeest can be in-
fected in utero, and suggesting that placenta could play a role in MCF transmission. The higher
AlHV-1 DNA detection rate in the younger cohort of wildebeest calves is consistent with previ-
ous observations that infection of wildebeest generally occurs within the first month of life and
that viraemia peaks between one and two months. The discovery of new A9.5 alleles supports
previous evidence that the gene is highly polymorphic and appears to encode a secretory protein
with IL-4 as the major homologue. Differences in the alleles detected in Tarangire and Ngoron-
goro Crater suggest that geographical and evolutionary separation of wildebeest populations
[28] may have influenced the AlHV-1 alleles found. In contrast, the observation that the most
frequently detected Tanzanian AlHV-1 haplotype was identical to the C500 virus suggests that
AlHV-1 C500 is an appropriate strain for vaccine development and supports the view that
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AlHV-1 virus genotypes are stable over time. More extensive collection of samples from across
the wildebeest range will enable the diversity of AlHV-1 strains to be further elucidated.
Supporting Information
S1 Data. The full set of A9.5 gene sequence data. The gene was successfully amplified from
26 AlHV-1 positive wildebeest samples and six AlHV-1 positive vaccine trial cattle samples
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S2 Data. The full set of ORF50 gene sequence data. The gene was successfully amplified from
38 AlHV-1-positive placenta samples
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S1 Fig. Alignment of the sequences of ORF50 PCR products determined in this work. The
ORF500101 allele has sequence identical to that in the AlHV-1 genome sequence [31]. Nucle-
otide differences from the ORF500101 sequence are shown by grey highlights. The order of se-
quences in the alignment is optimised to reflect the major clades in Fig 1 defined by the C-T
polymorphism at position 457. The three-letter translation of ORF500101 is shown below the
alignment, with residues altered by base substitutions in alleles ORF500201, 0301 and 0401
indicated by underlining.
(TIFF)
S2 Fig. Alignment of the sequences of A9.5 PCR products determined in this work. The po-
sitions of exons (uppercase) and introns (lowercase) were defined by comparison with the A9.501
sequence [24]. The flanking sequences in the A9.50101 allele that were used as primers are derived
from the AlHV-1 genome sequence31 and are underlined. In the other alleles, only nucleotides that
differ from the A9.50101 sequence are shown, while identities are represented by dots (.). Gaps, in-
serted to maintain alignment, are shown as dashes (-) and are found only in the introns.
(TIFF)
Acknowledgments
We are grateful for the cooperation of the Simanjiro Development Trust, Dr. Moses Ole-
Neselle and the people of Emboreet Village for their cooperation, for Richard Hoare and
Machunde Bigambo for the collection and provision of placenta samples, and to the staff at the
Nelson Mandela African Institution for Science and Technology, Arusha, Tanzania for access
to laboratory facilities and equipment.
Author Contributions
Conceived and designed the experiments: FL DH SC GR RK JK. Performed the experiments:
FL AL NM AN DG VR GR. Analyzed the data: FL DG DH SC GR. Contributed reagents/mate-
rials/analysis tools: NM AN DG VR GR. Wrote the paper: FL AL NM AN JK RK DG VR DH
SC GR. Obtained permission for study in Tanzania: RK JK.
References
1. Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ. The family of Herpes-
viridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Virus-
es. Arch Virol. 1992; 123:425–49. PMID: 1562239
2. Hart J, Ackermann M, Jayawardane G, Russell G, Haig DM, Reid H, et al. Complete sequence and
analysis of the ovine herpesvirus 2 genome. J Gen Virol [Internet]. 2007 Jan [cited 2013 Mar 27];
88(Pt 1):28–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17170433 PMID: 17170433
Alcelaphine Herpesvirus-1 in Wildebeest Placenta
PLOS ONE | DOI:10.1371/journal.pone.0124121 May 13, 2015 12 / 14
3. Plowright W, Ferris RD, Scott GR. Blue wildebeest and the aetiological agent of bovine malignant ca-
tarrhal fever. Nature. 1960; 188:1167–8. PMID: 13736396
4. Chmielewicz B, Goltz M, Ehlers B. Detection and multigenic characterization of a novel gammaherpes-
virus in goats. Virus Res [Internet]. 2001 May; 75(1):87–94. Available from: http://www.ncbi.nlm.nih.
gov/pubmed/11311431 PMID: 11311431
5. Li H, Keller J, Knowles DP, Crawford TB. Recognition of another member of the malignant catarrhal
fever virus group: an endemic gammaherpesvirus in domestic goats. J Gen Virol [Internet]. 2001 Jan;
82(Pt 1):227–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11125175 PMID: 11125175
6. Li H, Dyer N, Keller J, Crawford TB. Newly recognized herpesvirus causing malignant catarrhal fever in
white-tailed deer (Odocoileus virginianus). J Clin Microbiol [Internet]. 2000 Apr; 38(4):1313–8. Available
from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=86438&tool = pmcentrez&rendertype =
abstract PMID: 10747100
7. Kleiboeker SB, Miller MA, Schommer SK, Ramos-vara JA, Boucher M, Turnquist SE. Detection and
Multigenic Characterization of a Herpesvirus Associated with Malignant Catarrhal Fever in White-Tailed
Deer (Odocoileus virginianus) fromMissouri. 2002; 40(4):1311–8. PMID: 11923350
8. Klieforth R, Maalouf G, Stalis I, Terio K, Janssen D, Schrenzel M. Malignant Catarrhal Fever-Like Dis-
ease in Barbary Red Deer (Cervus elaphus barbarus) Naturally Infected with a Virus Resembling Alce-
laphine Herpesvirus 2 †. J Clin Microbiol. 2002; 40(9):3381–90. PMID: 12202582
9. Mushi EZ, Rossiter PB, Jessett D, Karstad L. Isolation and characterization of a herpesvirus from topi
(Damaliscus korrigum, Ogilby). J Comp Pathol. 1981; 9(1):63–8.
10. Plowright W. Malignant catarrhal fever virus: a lymphotropic herpesvirus of ruminants. In: Wittmann G,
Gaskell RM, Rziha HJMN, editors. In Latent Herpes Virus Infections in Veterinary Medicine. Commis-
sion of the European Community; 1984. p. 279–305.
11. Schultheiss PC, Collins JK, Spraker TR, DeMartini JC. Epizootic malignant catarrhal fever in three bison
herds: differences from cattle and association with ovine herpesvirus-2. J Vet Diagn Invest [Internet]. 2000
Nov; 12(6):497–502. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11108448 PMID: 11108448
12. Taus NS, O’Toole D, Herndon DR, Cunha CW,Warg J V, Seal BS, et al. Malignant catarrhal fever in
American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2. Vet Microbiol [In-
ternet]. Elsevier B.V.; 2014 Aug 6 [cited 2014 Sep 25]; 172(1–2):318–22. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/24803260
13. Kim O, Li H, Crawford TB. Demonstration of sheep-associated malignant catarrhal fever virions in
sheep nasal secretions. Virus Res [Internet]. 2003 Dec [cited 2013 Mar 19]; 98(2):117–22. Available
from: http://linkinghub.elsevier.com/retrieve/pii/S0168170203002600 PMID: 14659558
14. Mushi EZ, Karstad L, Jessett D. Isolation of bovine malignant catarrhal fever virus from ocular and
nasal secretions of wildebeest calves. Res Vet Sci. 1980; 29:168–71. PMID: 7193339
15. Plowright W. Malignant Catarrhal Fever in East Africa: Behaviour of the virus in free-living populations
of blue wildebeest (Gorgon taurinus taurinus, Burchell). Res Vet Sci. 1965; 6:56–83. PMID: 14281668
16. Li H, Taus NS, Lewis GS, Kim O, Traul DL, Crawford TB. Shedding of Ovine Herpesvirus 2 in Sheep
Nasal Secretions: the Predominant Mode for Transmission. J Clin Microbiol. 2004; 42(12):5558–64.
PMID: 15583281
17. Plowright W. Malignant Catarrhal Fever. J Am Vet Med Assoc. 1968; 152(6):795–805.
18. Buxton D, Reid HW. Transmission of malignant catarrhal fever to rabbits. Vet Rec. 1980; 106:243–5.
PMID: 7189075
19. Taus NS, Oaks JL, Gailbreath K, Traul DL, O’Toole D, Li H. Experimental aerosol infection of cattle
(Bos taurus) with ovine herpesvirus 2 using nasal secretions from infected sheep. Vet Microbiol [Inter-
net]. 2006 Aug 25 [cited 2013 May 19]; 116(1–3):29–36. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/16621344
20. Haig DM, Grant D, Deane D, Campbell I, Thomson J, Jepson C, et al. An immunisation strategy for the
protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever. Vaccine [Inter-
net]. 2008 Aug 18 [cited 2013 Mar 27]; 26(35):4461–8. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/18601965 doi: 10.1016/j.vaccine.2008.06.056 PMID: 18601965
21. Cleaveland S, Kusiluka L, Ole Kuwai J, Bell C, Kazwala R. Assessing the impact of malignant catarrhal
fever in Ngorongoro District, Tanzania. Report to the DFID Animal Health Programme, Centre for Tropi-
cal Veterinary Medicine, University of Edinburgh. 2001.
22. Pretorius JA, Oosthuizen MC, Van Vuuren M. Gammaherpesvirus carrier status of black wildebeest
(Connochaetes. J S Afr Vet Assoc. 2008; 79(3):136–41. PMID: 19244822
23. Rossiter PB, Jessett DM, Karstad L. Role of wildebeest fetal membranes and fluids in the transmission
of malignant catarrhal fever virus. Vet Rec. 1983; 113:150–2. PMID: 6623872
Alcelaphine Herpesvirus-1 in Wildebeest Placenta
PLOS ONE | DOI:10.1371/journal.pone.0124121 May 13, 2015 13 / 14
24. Russell GC, Todd H, Deane D, Percival A, Dagleish MP, Haig DM, et al. A novel spliced gene in alcela-
phine herpesvirus 1 encodes a glycoprotein which is secreted in vitro. J Gen Virol [Internet]. 2013 Nov
[cited 2014 Jun 26]; 94(Pt 11):2515–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
23956300 doi: 10.1099/vir.0.055673-0 PMID: 23956300
25. Russell GC, Scholes SF, Twomey DF, Courtenay AE, Grant DM, Lamond B, et al. Analysis of the ge-
netic diversity of ovine herpesvirus 2 in samples from livestock with malignant catarrhal fever. Vet
Microbiol [Internet]. Elsevier B.V.; 2014 Aug 6 [cited 2014 Jul 10]; 172(1–2):63–71. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/24846753
26. Plowright W, Herniman KAJ, Jesset DM, Kalunda M, Rampton CS. Immunisation of cattle against the
herpesvirus of malignant catarrhal fever: failure of inactivated culture vaccines with adjuvant. Res Vet
Sci. 1975; 19:159–66. PMID: 1166120
27. Whitaker KA, Wessels ME, Campbell I, Russell GC. Outbreak of wildebeest-associated malignant ca-
tarrhal fever in Ankole cattle. Vet Rec. 2007; 161:692–5. PMID: 18024925
28. Georgiadis N. Structure of Wildebeest: Implications for Conservation. In: Sinclaire A, Arcese P, editors.
Serengeti II: Dynamics, Management, and Conservation of an Ecosystem. Chicago and London: The
University of Chicago Press; 1995. p. 473–84.
29. Russell GC, Benavides J, Grant D, Todd H, Deane D, Percival A, et al. Duration of protective immunity
and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant ca-
tarrhal fever. Vet Res [Internet].???; 2012 Jan [cited 2014 Jun 6]; 43(1):51. Available from: http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=3425131&tool = pmcentrez&rendertype = abstract
30. Li H, Gailbreath K, Flach EJ, Taus NS, Cooley J, Keller J, et al. A novel subgroup of rhadinoviruses in
ruminants. J Gen Virol [Internet]. 2005 Nov [cited 2013 Mar 27]; 86(Pt 11):3021–6. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16227223 PMID: 16227223
31. Ensser a, Pflanz R, Fleckenstein B. Primary structure of the alcelaphine herpesvirus 1 genome. J Virol
[Internet]. 1997 Sep; 71(9):6517–25. Available from: http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=191927&tool = pmcentrez&rendertype = abstract PMID: 9261371
32. Traul DL, Elias S, Taus NS, Herrmann LM, Oaks JL, Li H. A real-time PCR assay for measuring alcela-
phine herpesvirus-1 DNA. J Virol Methods [Internet]. 2005 Nov [cited 2013 Mar 27]; 129(2):186–90.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15998545 PMID: 15998545
33. Flach E.,Reid H, Pow I, Klemt A. Gamma herpesvirus carrier status of captive artiodactyls. Res Vet Sci
[Internet]. 2002 Aug [cited 2013 May 19]; 73(1):93–9. Available from: http://linkinghub.elsevier.com/
retrieve/pii/S0034528802000942 PMID: 12208112
34. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen J a M. Primer3Plus, an enhanced
web interface to Primer3. Nucleic Acids Res [Internet]. 2007 Jul [cited 2014 May 30]; 35(Web Server
issue):W71–4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1933133&tool = pmcentrez&rendertype = abstract
35. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic
Acids Res [Internet]. 2004 Jan [cited 2014 Jul 11]; 32(5):1792–7. Available from: http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=390337&tool = pmcentrez&rendertype = abstract
PMID: 15034147
36. Katoh K, Standley DM. MAFFTmultiple sequence alignment software version 7: improvements in per-
formance and usability. Mol Biol Evol [Internet]. 2013 Apr [cited 2014 Jul 13]; 30(4):772–80. Available
from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3603318&tool =
pmcentrez&rendertype = abstract doi: 10.1093/molbev/mst010 PMID: 23329690
37. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Anal-
ysis version 6.0. Mol Biol Evol [Internet]. 2013 Dec [cited 2014 Jul 9]; 30(12):2725–9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/24132122 doi: 10.1093/molbev/mst197 PMID: 24132122
38. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative
studies of nucleotide sequences. J Mol Evol. 1980; 16:111–20. PMID: 7463489
39. Rweyemamu MM, Karstad L, Mushi EZ, Otema JC, Jessett DM, Rowe L, et al. Malignant catarrhal
fever virus in nasal secretions of wildebeest: A probable mechanism for virus tranmsission. J Wildl Dis.
1974; 10:478–87. PMID: 4436931
40. Barnard BJ., Bengis RG, Griessel MD, DE Vos V. Excretion of Alcelaphine herpesvirus-1 by captive
and free-living wildebeest (Connochaetes taurinus). Onderstepoort Jounral Vet Res. 1989; 56:131–4.
PMID: 2748133
41. Whelan S, GoldmanN. A General Empirical Model of Protein Evolution Derived fromMultiple Protein
Families Using a Maximum-Likelihood Approach. Mol Biol Evol. 2001; 18:691–9. PMID: 11319253
42. McGeoch DJ, Gatherer D, Dolan A. On phylogenetic relationships among major lineages of the Gam-
maherpesvirinae. J Gen Virol [Internet]. 2005 Feb [cited 2013 May 19]; 86(Pt 2):307–16. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/15659749 PMID: 15659749
Alcelaphine Herpesvirus-1 in Wildebeest Placenta
PLOS ONE | DOI:10.1371/journal.pone.0124121 May 13, 2015 14 / 14
